Results 231 to 240 of about 39,716 (256)

DNA methyltransferase inhibitors in hematological malignancies and solid tumors

open access: yesInternational Journal of Cancer, Volume 158, Issue 2, Page 433-461, 15 January 2026.
Abstract Epigenetic modifications such as DNA methylation play a fundamental role in oncogenesis and the progression of neoplasms neoplasias. DNA methyltransferase inhibitors (DNMTi) constitute a family of therapeutic agents that impede the methylation at the 5‐position on cytosine nucleotides, thereby modulating the epigenetic regulation of tumor ...
Valentin Wenger   +3 more
wiley   +1 more source

Predicting Danish EQ-5D-5L Utilities Based on United Kingdom EQ-5D-3L Utilities for Use in Health Economic Models. [PDF]

open access: yesPharmacoecon Open
Torkilseng EB   +8 more
europepmc   +1 more source

Assessment of health-related quality of life in individuals with depressive symptoms: validity and responsiveness of the EQ-5D-3L and the SF-6D. [PDF]

open access: yesEur J Health Econ, 2023
Stolz M   +13 more
europepmc   +1 more source

Health-Related Quality of Life in Patients with Friedreich Ataxia Using Mobility Assistive Technologies: Limited Fit of the EQ-5D-3L Mobility Dimension. [PDF]

open access: yesNeurol Ther
Buchholz M   +8 more
europepmc   +1 more source

Quality of life of patients with cutaneous leishmaniasis: A comparative analysis of the EQ-5D-3L and CLIQ questionnaires. [PDF]

open access: yesPLoS One
Galvão EL   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy